SEARCH

SEARCH BY CITATION

References

  • Belmaker RH. (2004) Bipolar disorder. N Engl J Med 351:476486.
  • Berridge MJ, Downes CP, Hanley MR. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411419.
  • Bersudsky Y, Applebaum J, Gaiduk Y, Sharony L, Mishory A, Podberezsky A, Agam G, Belmaker RH. (2010) Valnoctamide as a valproate substitute with low teratogenic potentials in mania; a double-blind, controlled add-on clinical trial. Bipolar Disord 12:376382.
  • Bialer M. (1991) Clinical pharmacology of valpromide. Clin Pharmacokinet 20:114122.
  • Bialer M, White HS. (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9:6883.
  • Bialer M, Yagen B. (2007) Valproic acid – second generation. Neurotherapeutics 4:130137.
  • Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. (2010) Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res 92:89124.
  • Blackburn-Munro G, Erichsen HK. (2005) Antiepileptics and the treatment of neuropathic pain: evidence from animal models. Curr Pharm Des 11:29612976.
  • Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janocak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino S, Risch SC, Goodnick PJ, Morris DD, for the Depakote ER Mania Study Group. (1994) Efficacy of divalrpoex vs lithium and placebo in the treatment of mania. JAMA 771:918924.
  • Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, Abi-Saab W, Saltarelli M, for the Depakote ER Mania Study Group. (2006) A randomized placebo controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 67:15011510.
  • Brill V, England J, Franklin GM, Backonja M, Choen J, Del R, Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D. (2011) Evidence-based guideline: treatment of painful diabetic neuropathy. Neurology 76:17581765.
  • Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan RE, Rudd GD. (1999) A double blind placebo-controlled study of lamotrigine in our patients with bipolar I depression. J Clin Psychiatry 60:7988.
  • Chen G, Huang LD, Jiang YM, Manji HK. (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72:13271330.
  • Devor M. (2006) Response of nerves to injury in relation to neuropathic pain. In McMahon S, Koltzenburg M (Eds) Wall & Melzack’s textbook of pain, 5th edn. Churchill Livingstone, London, pp. 905927.
  • Devor M. (2009) How does gabapentin relieve neuropathic pain? Pain 145:259263.
  • Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:289305.
  • Garnett WR. (2002) Lamotrigine- interactions with other drugs. In Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds) Antiepileptic drugs, 5th edn. Lippincott Williams and Wilkins, New York, pp. 380388.
  • Geddes J. (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders; a systemic review and meta-analysis. Lancet 361:799808.
  • Gill D, Derry S, Wiffen PJ, Moore RA. (2011) Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults (Review). Cochrane Database Syst Rev 10:CD009183.
  • Gilron I, Coderre TJ. (2007) Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs 12:113126.
  • Goodyear-Smith F, Halliwell J. (2009) Anticonvulsants for neuropathic pain: gaps in the evidence. Clin J Pain 25:528536.
  • Grunze HCR. (2010) Anticonvulsants in bipolar disorder. J Ment Health 1:127141.
  • Hearn L, Derry S, Moore RA. (2012) Lacosamide for neuropathic pain and fibromyalgia in adults (Review). Cochrane Database Syst Rev 2:CD009318.
  • Johannessen Landmark C. (2008) Antiepileptic drugs in non-epilepsy disorders. CNS Drugs 22:2747.
  • Kaufman RK. (2011) Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav 21:111.
  • Kaufmann D, Yagen B, Minert A, Wlodarczyk B, Finnell R, Schurig V, Devor M, Bialer M. (2010) Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid. Neuropharmacology 58:12281236.
  • Loscher W. (2002) Valproic acid mechanism of action. In Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds) Antiepileptic drugs, 5th edn. Lippincott Williams & Wilkins Publishers, New York, pp. 767779.
  • Macdonald KJ, Young LT. (2002) Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy. CNS Drugs 16:549562.
  • Machado-Vieira R, Kapczinski F, Soares JC. (2004) Perspectives of the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:209224.
  • Mackey C. (2010) The anticonvulsants market. Nat Rev Drug Discov 9:265266.
  • Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M. (2010) Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol 9:413424.
  • Margineanu DG. (2011) Systems biology impact of antiepileptic drug discovery. Epilepsy Res 50:7178.
  • McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. (1995) Anticonvulsant drugs for management of pain: a systematic review. BMJ 311:10471052.
  • Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. (2009) Pregabalin for acute and chronic pain in adults (Review). Cochrane Database Syst Rev 23:CD007076.
  • Moore RA, Wiffen PJ, Derry S, McQuay HJ. (2011) Gabapentin for chronic neuropathic pain and fibromyalgia in adults (Review). Cochrane Database Syst Rev 3:CD007938.
  • Mukherjee S, Sackeim HA, Schnur DB. (1994) Electroconvulsive therapy of acute manic episodes; a review of 50 years’ experience. Am J Psychiatry 151:169176.
  • Nalivaeva NN, Belyaev NCD, Turner AJ. (2009) Sodium valproate: an old drug with new roles. THIPS 30:509514.
  • Pan HI, Eisenbach JC, Chen CR. (1999) Gabapentin suppresses ectopic nerve discacharges and revese allodynia in nueropathic rats. J Pharamcol Exp Ther 288:10261030.
  • Post RM, Weiss SR. (1996) A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol Neurol 13:3360.
  • Post RM, Weiss SR. (2004) Convergence in course of illness and treatments of the epilepsies and recurrent affective disorders. Clin EEG Neurosci 35:1424.
  • Rogawski M, Loscher W. (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10:685692.
  • Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, Harwood AJ, Belmaker RH, Greenberg ML, Agam G. (2004) Valproate decreases inositol biosynthesis. Biol Psychiatry 56:868874.
  • Shaltiel G, Shirley M, Kofman O, Belmaker RH, Agam G. (2007) Effect of valproate derivatives on human brain myo-insoitol-1-phosphate (MIP) synthase activity and amphetamine-induced rearing. Pharmacol Rep 59:402407.
  • Souppart C, Gardin A, Greig G, Balez S, Batard Y, Kerbs-Brown A, Appel-Dingemanse S. (2008) Pharmacokinetics of licarbazepine in healthy volunteers: single and multiple oral doses and effect of food. J Clin Pharmacol 48:563569.
  • Supuran CT. (2012) Carbonic anhydrase inhibitors as emerging drugs of eth treatment of obesity. Expert Opin Emerg Drugs 17:1115.
  • Taylor C. (2009) Mechanisms of analgesia by gabapentin and pregabalin-calcium channel α2-δ ligands. Pain 142:1316.
  • Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V. (2003) Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmcol 140:255260.
  • Weisler RH, Katali AH, Ketter TA. (2004) A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65:478484.
  • Weisler RH, Keck PE, Swann AC, Cutler AJ, Ketter TA, Kalai AH. (2005) Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 66:323330.
  • Weisler RH, Cutler AJ, Ballenger JC, Post RM, Ketter TA. (2006) The use of antiepileptic drugs in bipolar disorders: a review based on evidence form controlled trials. CNS Spectr 11:788799.
  • Williams RS, Cheng L, Mudge AW, Harwood AJ. (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417:292295.
  • Yang RH, Wang WT, Chen JY, Xie RG, Hu SJ. (2009) Gabapentin selectively reduces persistent sodium current in injured type-A dorsal root ganglion neurons. Pain 143:855.
  • Yogeeswari P, Vaigunda Ragavendran J, Sriram D. (2007) Neuropathic pain: strategies in drug discovery and treatment. Expert Opin Drug Discov 2:169184.